申请人:Hoffmann-La Roche Inc.
公开号:US04489003A1
公开(公告)日:1984-12-18
There are described novel pharmaceutically active substances which have a pronounced affinity to the central benzodiazepine receptors and which have only a low toxicity. These active substances, namely imidazobenzodiazepines of the formula ##STR1## wherein A is lower alkylene, n is zero or 1, R.sup.1 is lower alkynyl, lower alkenyl, aryl, (C.sub.3-8)-cycloalkyl optionally substituted by lower alkyl or (C.sub.5-8)-cycloalkenyl optionally substituted by lower alkyl, or a 5- or 6-membered saturated or unsaturated heterocycle which contains an oxygen or sulphur atom as a ring member and which is optionally substituted by lower alkyl, R.sup.4 and R.sup.5 each are hydrogen, halogen, trifluoromethyl, cyano, nitro, amino or lower alkyl and either R.sup.2 is hydrogen and R.sup.3 is lower alkyl or R.sup.2 and R.sup.3 together are dimethylene, trimethylene or propenylene, the compounds of formula I in which R.sup.2 and R.sup.3 together are dimethylene, trimethylene or propenylene having the (S) or (R,S) configuration with reference to the carbon atom denoted by .gamma., and their pharmaceutically acceptable acid addition salts, can be used as medicaments in the form of pharmaceutical preparations, especially in the control of convulsions and anxiety states and/or in the partial or complete antagonization of some or all activities which 1,4-benzodiazepines having tranquillizing activity or other substances display via the central benzodiazepine receptors.
描述了一种新型具有显著亲和力的药用活性物质,它们对中枢苯二氮卓类受体具有高亲和力,且毒性低。这些活性物质,即具有以下结构的咪唑苯二氮卓类化合物:其中A为较低的烷基,n为零或1,R1为较低的炔基、较低的烯基、芳基、(C3-8)-环烷基(可选择地被较低的烷基取代)或(C5-8)-环烯烷基(可选择地被较低的烷基取代),或者是含有氧或硫原子作为环成员的5-或6-成员饱和或不饱和杂环,且可选择地被较低的烷基取代,R4和R5各自为氢、卤素、三氟甲基、氰基、硝基、氨基或较低的烷基,而R2为氢且R3为较低的烷基,或者R2和R3一起为二甲亚乙烷、三甲亚乙烷或丙烯亚乙烷,其中R2和R3一起为二甲亚乙烷、三甲亚乙烷或丙烯亚乙烷的具有对应于由γ表示的碳原子的(S)或(R,S)构型的I式化合物,以及它们的药学上可接受的酸盐加合物,可作为药物用于制备药物制剂,特别用于控制癫痫和焦虑状态,或者部分或完全拮抗一些或全部1,4-苯二氮卓类具有镇静作用或其他物质通过中枢苯二氮卓类受体表现出的活性。